Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hopefully a typo, May 2023..
Several large investors have recently made changes to their positions
I found this on stocktwits
I don't think this has been posted here yet.
Toward the bottom of the article they state which hedge funds increased amrn shares.
https://www.marketbeat.com/instant-alerts/nasdaq-amrn-analyst-earnings-estimates-2024-01-01/
Several large investors have recently made changes to their positions in the business. Morgan Stanley boosted its position in shares of Amarin by 289.6% during the 4th quarter. Morgan Stanley now owns 22,027,895 shares of the biopharmaceutical company's stock valued at $26,654,000 after purchasing an additional 16,373,362 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Amarin by 292.2% in the fourth quarter. Millennium Management LLC now owns 6,923,801 shares of the biopharmaceutical company's stock worth $8,378,000 after buying an additional 5,158,279 shares during the period. Two Sigma Investments LP boosted its holdings in shares of Amarin by 33.5% in the first quarter. Two Sigma Investments LP now owns 5,560,983 shares of the biopharmaceutical company's stock worth $8,341,000 after buying an additional 1,395,665 shares during the period. Sarissa Capital Management LP boosted its holdings in shares of Amarin by 2.1% in the first quarter. Sarissa Capital Management LP now owns 4,910,000 shares of the biopharmaceutical company's stock worth $7,365,000 after buying an additional 103,000 shares during the period. Finally, Clearbridge Investments LLC boosted its holdings in shares of Amarin by 0.9% in the first quarter. Clearbridge Investments LLC now owns 4,789,575 shares of the biopharmaceutical company's stock worth $15,758,000 after buying an additional 42,012 shares during the period. Institutional investors own 25.51% of the company's stock.
This is a link to a comment on ST about a AD conference in Boston this week. In the comments there is a link to a pdf concerning the BRAVE study. Dr.Carlsson was one of the authors.
https://stocktwits.com/Behold_A_Pale_Horse/message/550100709
This from ST. Vascepa selling in mainland China.
https://stocktwits.com/symbol/AMRN
FFS, based on your analysis where is this PPS going? Sub $1.00? If so, how low?
North40000,
My script from CVS also states Insurance only covers brand alternative of prescribed drug.
I'm in the SF Bay area CA. Something has definitely changed with this, it was a real hassle to get V before. They never had it locally and I had to set up messaging to let me know when it arrived at my local pharmacy. Not anymore, I pay $30 for 90 days. It's available and they text me when it's ready..BTW, the pharmacist told me that it was cardinal health that was the medicine wholesaler.. and they were the problem with getting it on time. This was prior to Holt becoming the AMRN CEO. Perhaps he had something to do with this IDK!?
LM,
Do you believe that Pat Holts buy in today was a coincidence with this release?
This from ST FWIW on the trade.
Also check out Pharmacy dudes post on the Canadian pharmacy letter promoting Vascepa vs O3 supplements
https://stocktwits.com/SanDiegoLiving
Denisk, try this person. She responded to my questions in 2019.
Elena Beckman
Research Specialist
Cindy Carlsson’s Lab
Wisconsin Alzheimer’s Disease Research Center
GRECC C-5, VA Hospital
608-256-1901 x11199
ebeckman@medicine.wisc.edu
Bfost, thanks for posting.
I looked up the FPN magazine and here's what I found.
Published monthly, FPN circulates to more than 103,000 family physicians and related subspecialists and features articles researched, written, and produced by professional medical journalists.
Aetna choice is the new insurance (premium medical plan)
Pharmacy plan is CVS caremark
I just paid $30 for a 3 month supply of V at 4g/day with CVS caremark.. My company changed insurance plans. I'm on the central coast of California. I had BCBS and they would not cover it at all. I was paying for it myself. I emailed my cardiologist about the prescription with links to Reduce IT and Evaporate, asking for DAW, I received a one word reply. Done.. Good man! I have very high triglycerides, nothing else but that.
Amarins response to SanDiegoLiving inquiries about the embargoed KP information.
https://stocktwits.com/SanDiegoLiving
This is a post on stocktwits from SanDiegoliving about the embargoed KP information.
https://stocktwits.com/SanDiegoLiving/message/522437719
One more link and an email address at the bottom if your inquiry doesn't get a response.
https://www.adrc.wisc.edu/brave-study
Rosemountbomber,
Prior to the last extension of the BRAVE study I had emailed Cynthia M. Carlsson, the PI and she personally replied within a couple of days..
Monk44,
Perhaps stockboy meant this gentleman?
https://people.uwe.ac.uk/Person/Jonathon2Hull
A post concerning Alzheimer's and V from Stock twits. A real world observation. Post below
SanDiegoLiving
Mar 23, 2023 1:29 PM
$AMRN If this is true...look out ??????.
Brave is measuring changes in biomarkers as one of their endpoints to the study.
Side note: My aunt is two years in on vascepa and is currently in the mile to moderate stage of disease progression.
Her memory is not getting worse. Beginning to remember street names and small details that were greatly impacted by her short-term memory. Obviously I'm not doing any Data and testing but I've been around her enough to know how to see the trend in how rapidly her memory was declining over the years
The real question is when does EPA reach peak concentration in the brain where apparently uptake is incredibly slow? If event lines separated at about 18 months for evaporate and reduce it, how much longer does it take for the brain? I would assume a lot longer due to it's selectively permeable nature.
Still hoping and praying for a miracle with my aunt, but incredibly encouraged and excited by some noticeable improvements
Number sleven
Thank you for the post. I've always appreciated your posts
Karim's swan song indeed
Old school
Use the TDA messaging feature in the app to ask for the blue proxy card number and they will get it done in hours.
Maui,
I for one received both the blue and white via my personal email account. But only after they sent me the control number for the white proxy card on the TDA apps secure messaging feature. I asked them for the blue card control number and it was in my in box the next day, this morning actually.
Hi Cap,
TDA sent me the control number for the white card today via the apps secure messaging feature after asking for the blue proxy card number over the weekend. I responded by asking for the blue proxy card number today. I now have 2 sets of numbers to vote with. I requested the update around 4 hours ago.. good luck to you.
Wolf1, I apologize I sent this to you by mistake. You were asking about Merrill but it might be helpful to someone else.
I have sent TDA an email from my account messaging feature and this is where to find the proxy vote info when it arrives. It has not arrived in my case. I received the email today. BTW you have to log into a computer not a mobile device. The mobile app doesn't show the "my account" heading. The message to me is below:
I would be happy to clarify where you can find this voting information. To find this information, you would need to ensure that you are accessing your account on the TD Ameritrade website (invest.ameritrade.com). Once you have logged into your account on this website, you would then see a heading that reads "My Account". If you click on this a drop down menu will appear, and this is where you would then want to look for History & Statements > Shareholder Library.
Any voting information would be listed on this page.
Please let us know if you have any other questions or concerns by replying to this message. You may also call us 24/7 at 800-669-3900.
TDA and Merrill, my two brokerage accounts knew nothing about this proxy vote. I shared the Sarissa web site with both, hopefully it will help us/me vote my shares.
Yes, Yes
Hi Lizzy,
I had sent emails to a couple of eddingpharm employees only to get a bounce back of the email as undeliverable. This was months ago though.
Eva Bao was one that I recall. Hopefully you get a response. Thanks for trying.
Nuke, one hour later than pac time now, back then AK had 4 time zones
I don't recall large pumpkins but 100# cabbages, ive seen.
My mom, had my brother and I on a mission to get seed's from the big cabbages ( from the Mat/Su valley) but considering we'd have to eat cabbage/kraut with every meal, we couldn't find any, ever!.
BTW I lived in AZ for 12 years..the valley got to hot for me.. but I have a short memory. I miss the awesome off-roading there.
He is a great coach, we will see who gets the coach of the year award.
Zim vs O'Connell for the Vikings, hands down an improvement.
O'Connell bailing on the Rams has not been a benefit for your team.
Sports in general are always heartbreaking but I've been a Vikes fan for years and from a state without a team (AK) in any sport, I'm a vet of being disappointed...
I apologize to that I have responded to the wrong post.
Nice, pretty clever!
Gentlemen the best coach in league is KOC
Kevin O'Connoll.
The Vikes went from zero to hero. Im in Cal but I'm a Viking fan big time..Kirko Chainz is the man..
This is from Yahoo.
this came out this morning . Jefferies analyst Michael Yee upgraded Amarin to Buy from Hold with a price target of $3, up from $1.30. The shares are trading at a $200M enterprise value, or less than one-times peak European sales, and has some "strategic M&A optionality," a large activist investor working to drive change, and the company is not really burning cash anymore after cutting spending in 2022, Yee tells investors in a research note. In addition, Amarin's U.S. erosion has stabilized three quarters in a row, says the analyst. He also believes Amarin has been getting some good European pricing agreements. Yee calls the company "an intriguing small cap value play."